Perrigo's Papa to take helm at Valeant

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) named Joseph Papa chairman and CEO, effective in early May. He will replace longtime CEO Michael Pearson, who was also chairman until late February. Robert Ingram has been chairman since then, and will remain a director after Papa arrives.

Papa has resigned as CEO of generics company Perrigo Co. plc (NYSE:PRGO; Tel Aviv:PRGO), which promoted President John Hendrickson to CEO on Monday. ...